Literature DB >> 16085552

The importance of the telomere and telomerase system in hematological malignancies.

Ron Ram1, Orit Uziel, Meir Lahav.   

Abstract

Telomeres are specialized chromosomal end structures composed of repeat TTAGGG sequences in humans. They shorten with each cell division and thus serve as the "mitotic clock" of the cell. One of their main functions is the maintenance of chromosomal integrity and their excessive shortening is associated with DNA instability. Telomerase, a unique reverse transcriptase, is inactive in most somatic human cells and is up-regulated in most cancer cells. Recently, the biology of the telomere/telomerase system has attracted much attention because of its possible role in carcinogenesis and aging. In this article we review the biology of this system and its relevance to normal and malignant hematopoietic cells. The biological, diagnostic and prognostic value of telomere/telomerase biology is discussed, as well as its potential future applications in cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085552     DOI: 10.1080/10428190500125853

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia.

Authors:  Ali Amini; Seyed Hamidollah Ghaffari; Yousef Mortazavi; Yousef Mortazai; Karim Daliri; Shahrouz Taranejoo; Kamran Alimoghadam; Ardeshir Ghavamzadeh
Journal:  Mol Biol Rep       Date:  2014-09       Impact factor: 2.316

Review 2.  Telomere Length and Hematological Disorders: A Review.

Authors:  Beatriz Maria Dias Nogueira; Caio Bezerra Machado; Raquel Carvalho Montenegro; Maria Elisabete Amaral DE Moraes; Caroline Aquino Moreira-Nunes
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

3.  Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells.

Authors:  Anna Gutkin; Orit Uziel; Einat Beery; Jardena Nordenberg; Maria Pinchasi; Hadar Goldvaser; Steven Henick; Michal Goldberg; Meir Lahav
Journal:  Oncotarget       Date:  2016-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.